Article

Tracking Health Indicators After COVID-19 Requires Real-Time Capabilities

In this white paper from Humana, the authors discuss how the aftermath of COVID-19 will require the frequent use of screeners and tools to assess changes in health status, including health-related quality of life and social health. Taking into account the results that matter most to patients will be key to improving health outcomes.

What will health care require after COVID-19, which exposed disjointed care delivery, health-related social factors, and misaligned incentives? In this white paper from Humana, Andrew Renda, MD, Elizabeth B. Walden, MA, and Christiana Ilesanmi discuss how the swift and sudden innovation forced by the pandemic won't be complete without real-time tracking of health indicators that include patient-reported data to improve health outcomes.

Click on the PDF below to download.

Health care after COVID-19 rests on tracking leading health indicators in real-time

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Andrew Kuykendall, MD, Moffitt Cancer Center
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo